FDA Letter API

Duoc Thao Tre Xanh, LLC

Letter data

Company
Duoc Thao Tre Xanh, LLC
Recipient
Mr. Tin Huynh | Owner | Duoc Thao Tre Xanh, LLC | 9724 N Armenia Avenue | Suite 401a | Tampa | , | FL | 33612-7550 | United States | Tinhuynh@gmail.com
Issue date
2022-04-01
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East IV
Subject
Not available
Product
Dietary Supplements
CMS ID
611685
Reference number
22-HAFE4-WLCOL-08
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Duoc Thao Tre Xanh, LLC MARCS-CMS 611685 — April 01, 2022 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: 22-HAFE4-WLCOL-08 Product: Dietary Supplements Recipient: Recipient Name Mr. Tin Huynh Recipient Title Owner Duoc Thao Tre Xanh, LLC 9724 N Armenia Avenue Suite 401a Tampa , FL 33612-7550 United States Tinhuynh@gmail.com Issuing Office: Division of Human and Animal Food Operations East IV United States Dear Mr. Huynh: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter 21-HAFE4-WL-02 dated March 16, 2021. It appears that you have addressed the violations contained in this Warning Letter since the firm has been dissolved. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Kind regards, /S/ Pearl Lopina Director of Compliance Branch OHAFO East Division IV Content current as of: 04/19/2022 Regulated Product(s) Dietary Supplements